Summary

Hemodialysis Bloodline Systems Market
The hemodialysis bloodline systems market was valued at $1.6 billion in 2023 and is projected to reach $2.8 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.
A hemodialysis bloodline system is a part of the hemodialysis equipment that helps in the removal of excess fluids, waste, and toxins from a patient's blood. The equipment transports blood to & from patients during the procedure and ensures their safety by maintaining a controlled flow & preventing air bubbles or clot formation. The major advantages of a hemodialysis bloodline system are its efficiency of waste removal, ability to reduce the risk of infections, and improvement of patient comfort.

Increase in the prevalence of chronic kidney disease and end-stage renal disease across the globe is a key driver of the hemodialysis bloodline systems market. In addition, advancements in technology have led to improvements in equipment such as improved bloodline systems and pressure sensors, thereby driving the growth of the market significantly. To improve the biocompatibility of the equipment and minimize the risk of clotting & hemolysis, the usage of heparin-coated or hydrophilic-coated bloodlines is trending currently. These materials exhibit low inflammatory responses in the body of patients.
However, the recurrent costs associated with regular dialysis treatment deter several budget-sensitive patients from undergoing the treatment, thereby hampering the development of the market. Moreover, the shortage of skilled healthcare professionals to administer effective hemodialysis treatments restrains the hemodialysis bloodline systems market growth. On the contrary, rise in expenditure by governments across the globe to improve the healthcare infrastructure is anticipated to present lucrative opportunities for the hemodialysis bloodline systems market. For instance, a report by the WHO on global spending on health states that the total healthcare expenditure was approximately $ 9.8 trillion in 2021, which was a significant increase during the second year of the pandemic. Therefore, increase in awareness regarding the importance of building a robust health infrastructure is poised to open new avenues for the hemodialysis bloodline systems market.

Segment Review
The hemodialysis bloodline systems market is segmented into product, therapy type, end user, and region. On the basis of product, the market is divided into poly vinyl chloride (PVC) hemodialysis bloodline systems, polyethylene (PE) hemodialysis bloodline systems, polypropylene (PP) hemodialysis bloodline systems, and ABS hemodialysis bloodline systems. Depending on therapy type, it is classified into double needle therapy, single needle therapy, single needle crossover, and hemodiafiltration. As per end user, it is categorized into hospitals, clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the poly vinyl chloride (PVC) segment is expected to dominate the market during the forecast period.
Depending on therapy type, the double needle therapy segment is projected to acquire a high stake in the market by 2033.
As per end user, the hospitals segment is anticipated to be the highest shareholder throughout the forecast period.
Region wise, North America is predicted to be the highest revenue generator by 2033.
Competition Analysis
The major players in the global hemodialysis bloodline systems market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, Medtronic plc, B. Braun Melsungen AG, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd., Bain Medical Equipment (Guangzhou) Co., Ltd., Weigao Group Co., Ltd., and JMS Co., Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles
● Historic market data
Key Market Segments
By Product
● Poly Vinyl Chloride (PVC) Hemodialysis Bloodline Systems
● Polyethylene (PE) Hemodialysis Bloodline Systems
● Polypropylene (PP) Hemodialysis Bloodline Systems
● ABS Hemodialysis Bloodline Systems
By Therapy Type
● Double Needle Therapy
● Single Needle Therapy
● Single Needle Crossover
● Hemodiafiltration
By End User
● Hospitals
● Clinics
● Home Care Settings
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ France
○ Germany
○ Italy
○ Spain
○ UK
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA
● Key Market Players
○ Fresenius Medical Care AG & Co. KGaA
○ Baxter International Inc.
○ Nipro Corporation
○ Medtronic plc
○ B. Braun Melsungen AG
○ Nikkiso Co., Ltd.
○ Asahi Kasei Medical Co., Ltd.
○ Bain Medical Equipment (Guangzhou) Co., Ltd.
○ Weigao Group Co., Ltd.
○ JMS Co., Ltd.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HEMODIALYSIS BLOODLINE SYSTEMS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Poly Vinyl Chloride (PVC) Hemodialysis Bloodline Systems
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Polyethylene (PE) Hemodialysis Bloodline Systems
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Polypropylene (PP) Hemodialysis Bloodline Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. ABS Hemodialysis Bloodline Systems
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: HEMODIALYSIS BLOODLINE SYSTEMS MARKET, BY THERAPY TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Therapy Type
5.2. Double Needle Therapy
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Single Needle Therapy
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Single Needle Crossover
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Hemodiafiltration
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: HEMODIALYSIS BLOODLINE SYSTEMS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Clinics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Home Care Settings
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: HEMODIALYSIS BLOODLINE SYSTEMS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Therapy Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Hemodialysis Bloodline Systems Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Therapy Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Hemodialysis Bloodline Systems Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Therapy Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Hemodialysis Bloodline Systems Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Therapy Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Therapy Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Hemodialysis Bloodline Systems Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Therapy Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Hemodialysis Bloodline Systems Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Therapy Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Hemodialysis Bloodline Systems Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Therapy Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Hemodialysis Bloodline Systems Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Therapy Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Hemodialysis Bloodline Systems Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Therapy Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Hemodialysis Bloodline Systems Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Therapy Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Therapy Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Hemodialysis Bloodline Systems Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Therapy Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Hemodialysis Bloodline Systems Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Therapy Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Hemodialysis Bloodline Systems Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Therapy Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Hemodialysis Bloodline Systems Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Therapy Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Hemodialysis Bloodline Systems Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Therapy Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Hemodialysis Bloodline Systems Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Therapy Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Therapy Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Hemodialysis Bloodline Systems Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Therapy Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Hemodialysis Bloodline Systems Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Therapy Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Hemodialysis Bloodline Systems Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Therapy Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Hemodialysis Bloodline Systems Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Therapy Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Fresenius Medical Care AG And Co. KGaA
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Baxter International Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Nipro Corporation
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Medtronic Plc
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. B. Braun Melsungen AG
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Nikkiso Co., Ltd.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Asahi Kasei Medical Co., Ltd.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Bain Medical Equipment (Guangzhou) Co., Ltd.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Weigao Group Co., Ltd.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. JMS Co., Ltd.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments